Stock Analysis

The Price Is Right For Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198)

With a price-to-sales (or "P/S") ratio of 36.2x Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) may be sending very bearish signals at the moment, given that almost half of all the Medical Equipment companies in China have P/S ratios under 6x and even P/S lower than 3x are not unusual. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so lofty.

Check out our latest analysis for Beijing Balance Medical TechnologyLtd

ps-multiple-vs-industry
SHSE:688198 Price to Sales Ratio vs Industry February 7th 2025
Advertisement

How Has Beijing Balance Medical TechnologyLtd Performed Recently?

Recent times have been advantageous for Beijing Balance Medical TechnologyLtd as its revenues have been rising faster than most other companies. The P/S is probably high because investors think this strong revenue performance will continue. However, if this isn't the case, investors might get caught out paying too much for the stock.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Beijing Balance Medical TechnologyLtd.

Do Revenue Forecasts Match The High P/S Ratio?

There's an inherent assumption that a company should far outperform the industry for P/S ratios like Beijing Balance Medical TechnologyLtd's to be considered reasonable.

If we review the last year of revenue growth, the company posted a terrific increase of 22%. Pleasingly, revenue has also lifted 65% in aggregate from three years ago, thanks to the last 12 months of growth. Therefore, it's fair to say the revenue growth recently has been superb for the company.

Turning to the outlook, the next year should generate growth of 59% as estimated by the one analyst watching the company. Meanwhile, the rest of the industry is forecast to only expand by 24%, which is noticeably less attractive.

With this in mind, it's not hard to understand why Beijing Balance Medical TechnologyLtd's P/S is high relative to its industry peers. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

What Does Beijing Balance Medical TechnologyLtd's P/S Mean For Investors?

We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.

Our look into Beijing Balance Medical TechnologyLtd shows that its P/S ratio remains high on the merit of its strong future revenues. Right now shareholders are comfortable with the P/S as they are quite confident future revenues aren't under threat. It's hard to see the share price falling strongly in the near future under these circumstances.

There are also other vital risk factors to consider before investing and we've discovered 2 warning signs for Beijing Balance Medical TechnologyLtd that you should be aware of.

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Valuation is complex, but we're here to simplify it.

Discover if Beijing Balance Medical TechnologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SHSE:688198

Beijing Balance Medical TechnologyLtd

Beijing Balance Medical Technology Co.,Ltd.

Exceptional growth potential with solid track record.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ยท

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8227.1% undervalued
11 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ยท

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$960.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ยท

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6433.4% undervalued
15 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

BA
NVO logo
bactrian on Novo Nordisk ยท

A Quality Compounder Marked Down on Overblown Fears

Fair Value:US$9540.8% undervalued
95 users have followed this narrative
8 users have commented on this narrative
1 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ยท

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.454.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ALGN logo
yiannisz on Align Technology ยท

Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World

Fair Value:US$154.628.4% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AN
AnalystConsensusTarget
SFM logo
AnalystConsensusTarget on Sprouts Farmers Market ยท

SFM: Multi-Year Growth Plan Will Drive Renewed Momentum Despite Near-Term Challenges

Fair Value:US$124.2938.0% undervalued
42 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ยท

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ยท

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25429.4% overvalued
71 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative